These data collectively suggest that MMP-12-mediated macrophage activation is a primary contributor to dysregulated retinal angiogenesis and therefore might be a therapeutic target for neovascular retinal diseases. The gene discussed is MMP12; the disease is Abnormal retinal morphology.